NARI vs. IMVT

Last updated Apr 1, 2026

Compare and contrast key facts about Inari Medical, Inc. (NARI) and Immunovant, Inc. (IMVT).

Performance

NARI vs. IMVT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Inari Medical, Inc. (NARI) and Immunovant, Inc. (IMVT). The values are adjusted to include any dividend payments, if applicable.

NARI vs. IMVT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
NARI Inari Medical, Inc.	0.00%	56.65%	-21.36%	2.14%	-30.36%	4.56%	105.34%
IMVT Immunovant, Inc.	-2.28%	2.62%	-41.21%	137.35%	108.33%	-81.55%	130.83%

Fundamentals

Total Revenue (TTM) NARI : $574.50M IMVT : $0.00
Gross Profit (TTM) NARI : $494.08M IMVT : -$105.00K
EBITDA (TTM) NARI : -$36.16M IMVT : -$372.49M

Returns By Period

NARI

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

IMVT

• 1D: 5.48%
• 1M: -10.42%
• YTD: -2.28%
• 6M: 54.09%
• 1Y: 45.35%
• 3Y*: 17.00%
• 5Y*: 8.07%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

NARI vs. IMVT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IMVT

IMVT Risk / Return Rank: 69
IMVT Sharpe Ratio Rank: 69
IMVT Sortino Ratio Rank: 69
IMVT Omega Ratio Rank: 63
IMVT Calmar Ratio Rank: 72
IMVT Martin Ratio Rank: 70

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NARI vs. IMVT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Inari Medical, Inc. (NARI) and Immunovant, Inc. (IMVT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	NARI	IMVT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.82	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.11	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.09	—

Correlation

The correlation between NARI and IMVT is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

NARI vs. IMVT - Dividend Comparison

Neither NARI nor IMVT has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

Drawdown Indicators

	NARI	IMVT	Difference
Max Drawdown Largest peak-to-trough decline	—	-93.59%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-20.98%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-79.94%	—
Current Drawdown Current decline from peak	—	-52.87%	—
Average Drawdown Average peak-to-trough decline	—	-54.24%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	10.49%	—

Volatility

Volatility by Period

	NARI	IMVT	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	14.73%	—
Volatility (6M) Calculated over the trailing 6-month period	—	37.06%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	56.17%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	75.18%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	77.70%	—

Financials